Value Creation vs. Value Capture Analysis
Judge a company by how much benefit it creates for the world versus how much of that benefit it keeps.
- Difficulty
- Moderate
- Time to result
- ~ongoing to results
- Steps
- 6
- Confidence
- 85%
A recurring analytical lens the hosts use to evaluate whether a company's profits are justified: first estimate the total societal or customer value created by a product, then separately estimate how much of that value the company actually captures financially (margins, market cap, ROIC). Applied across a whole industry value chain, it distinguishes players who take real risk to create value (like pharma manufacturers funding failed R&D) from those who capture outsized returns without bearing commensurate risk (like insurers or PBMs with unusually stable profits). Benchmarking against industrywide ROIC, rather than headline margins, prevents mistaking a business's necessary compensation for risk-taking as 'overearning.'
Origin
A running segment on the Acquired podcast used to close out nearly every company analysis.
Core principles
- 01Gross margins alone are meaningless without netting out the cost of failures across a whole portfolio
- 02Compare a company's ROIC to industry peers, not just to its own revenue growth
- 03Volatile net income can be evidence of real risk-taking; suspiciously flat profits can be evidence of rent extraction
- 04Map every party in a value chain, not just the most visible one, before rendering judgment
How to run it
- 1
Define the value created
Identify the tangible benefit the product or service delivers to end users or society, and quantify it where possible (e.g., lives saved, quality-of-life improvement).
- 2
Define the value captured
Identify what financial returns the company actually keeps: revenue, margins, market cap, and return on invested capital.
- 3
Map the full value chain
List every party involved in delivering the product (manufacturer, distributor, retailer, intermediary, payer) and estimate value creation and capture for each.
- 4
Assess who actually bears risk
Determine which parties absorb losses when things go wrong versus which have contractually guaranteed take-rates regardless of outcomes.
Pro tip Look at the volatility of net income over time as a proxy for real risk-bearing.
- 5
Benchmark ROIC against peers
Compare the company's return on invested capital to the broader industry to judge whether returns are outsized or simply in line with the sector's risk profile.
Watch out Headline margins can look enormous even when industrywide ROIC is unremarkable once R&D failures are netted in.
- 6
Render a judgment
Synthesize the above into a view on whether the company's value capture is proportionate to the value it created and the risk it bore.
In the wild
Novo Nordisk created enormous patient value with insulin and GLP-1 drugs and also captured huge profits, but its industrywide ROIC is roughly in line with other capital-intensive sectors once R&D failures are considered, unlike health insurers whose profits stay flat even through crises like COVID.
→ The analysis reframes pharma as the risk-bearing innovator in healthcare, while flagging insurers and PBMs as capturing value disproportionate to the risk they take.
Common mistakes
Judging by gross margin alone
High margins on winning drugs ignore all the sunk R&D costs from failed drug candidates that those margins must also cover.
Equating revenue scale with overearning
A company can have huge revenue and still have unremarkable ROIC once true capital investment is accounted for.
Treating guaranteed-margin intermediaries as risk-bearers
Some healthcare 'insurers' post flat profits every year including during crises, showing they are not truly bearing risk the way the term insurance implies.
Is it for you?
Best for
Investors and analysts assessing whether an industry player's profits are earned or extracted
Not ideal for
Quick single-metric comparisons where a full value-chain map isn't feasible
From the transcript
“we talk about for for a given company how much value do they create in the world versus how much they capture”
“when you actually look at their return on invested Capital numbers the roic they are not through the roof they're like 133% industrywide”
“this is actually pretty interesting if you look at the net income of a Pharma company and let's just take the biggest one or a…”
From the episode
Novo Nordisk (Ozempic)